Utilization of Next-Generation Sequencing in Conjunction With Immunohistochemistry to Predict Exceptional Response to Combination Immune Checkpoint Therapy in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer.

Reizine, Natalie; Socco, Samantha; Weng, Eric; Atueyi, Uka; Mehta, Vikas; Patnaik, Akash

Reizine, Natalie; Socco, Samantha; Weng, Eric; Atueyi, Uka; Mehta, Vikas; Patnaik, Akash.

Afiliação

Reizine N; Division of Hematology and Oncology, Department of Medicine, The University of Illinois at Chicago, Chicago, IL.
Socco S; College of Pharmacy, The University of Illinois at Chicago, Chicago, IL.
Weng E; Division of Hematology and Oncology, Department of Medicine, The University of Illinois at Chicago, Chicago, IL.
Atueyi U; Department of Radiology, The University of Illinois at Chicago, Chicago, IL.
Mehta V; Department of Pathology, The University of Illinois at Chicago, Chicago, IL.
Patnaik A; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL.

JCO Precis Oncol ; 7: e2200483, 2023 03.

Article em En | MEDLINE | ID: mdl-36996374

Assuntos

Neoplasias de Próstata Resistentes à Castração; Masculino; Humanos; Neoplasias de Próstata Resistentes à Castração/tratamento farmacológico; Neoplasias de Próstata Resistentes à Castração/genética; Imuno-Histoquímica; Sequenciamento de Nucleotídeos em Larga Escala

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google